These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22727477)

  • 1. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A; Gomez R; Tenakoon L; Keller J; Cohen G; Williams GH; Kraemer FB; Schatzberg AF
    Psychoneuroendocrinology; 2013 Jan; 38(1):115-21. PubMed ID: 22727477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.
    Otte C; Yassouridis A; Jahn H; Maass P; Stober N; Wiedemann K; Kellner M
    J Gerontol A Biol Sci Med Sci; 2003 Oct; 58(10):B900-5. PubMed ID: 14570856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
    Otte C; Jahn H; Yassouridis A; Arlt J; Stober N; Maass P; Wiedemann K; Kellner M
    Life Sci; 2003 Aug; 73(14):1835-45. PubMed ID: 12888122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPA axis genetic variation, cortisol and psychosis in major depression.
    Schatzberg AF; Keller J; Tennakoon L; Lembke A; Williams G; Kraemer FB; Sarginson JE; Lazzeroni LC; Murphy GM
    Mol Psychiatry; 2014 Feb; 19(2):220-7. PubMed ID: 24166410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
    J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition.
    Cherian K; Schatzberg AF; Keller J
    Schizophr Res; 2019 Nov; 213():72-79. PubMed ID: 31307859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study.
    Demiralay C; Agorastos A; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    Psychiatry Res; 2015 May; 227(1):65-70. PubMed ID: 25799272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic--pituitary--adrenal (HPA) axis in humans.
    Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
    Pituitary; 2013 Sep; 16(3):378-85. PubMed ID: 23011321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol circadian rhythm alterations in psychotic major depression.
    Keller J; Flores B; Gomez RG; Solvason HB; Kenna H; Williams GH; Schatzberg AF
    Biol Psychiatry; 2006 Aug; 60(3):275-81. PubMed ID: 16458262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C; Reynolds RM; Simonyte K; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
    Schatzberg AF
    World J Biol Psychiatry; 2015 Jan; 16(1):2-11. PubMed ID: 24933348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates.
    Duval F; Mokrani MC; Monreal-Ortiz JA; Fattah S; Champeval C; Schulz P; Macher JP
    Psychoneuroendocrinology; 2006 Aug; 31(7):876-88. PubMed ID: 16769179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor function in major depression.
    Young EA; Lopez JF; Murphy-Weinberg V; Watson SJ; Akil H
    Arch Gen Psychiatry; 2003 Jan; 60(1):24-8. PubMed ID: 12511169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; D'Angelo V; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
    Endocrine; 2013 Feb; 43(1):51-8. PubMed ID: 22836869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
    Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.